A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients

Julien Pothlichet, Timothy B. Niewold, Damien Vitour, Brigitte Solhonne, Mary K. Crow, Mustapha Si-Tahar

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients'. Together they form a unique fingerprint.

Medicine & Life Sciences